## 



## 

## 

|Reference and Administrative<br>Details|||
|---|---|---|
|Trustees'<br>Report||2 to 6|
|Independent<br>Examiner's<br>Report||7to 8|
|Consolidated<br>Statement<br>of Financial|Activities||
|Consolidated<br>Balance Sheet||10|
|Balance Sheet|||
|Consolidated<br>Statement<br>ofCash Flows||12|
|Notes to the Financial Statements||13to 25|





## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 



## 

## 

|||Total|Recognised G|ains and Loss|es)||
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
|||Note|funds<br>E|funds<br>F|2021<br>f|2020<br>f.|
|Income and Endowments||from:|||||
|Donations<br>and legacies||2|9,626||9,626|148,751|
|Other trading<br>activities||3|202,161||202,161|284,293|
|Investment<br>income||4|224||224|1,253|
|Other income||5|34,689||34,689|4,088|
|Total income|||246,700||246,700|438,385|
|Expenditure<br>on:|||||||
|Raising funds|||(178,555)||(178,555)|(228,344)|
|Charitable<br>activities|||(109,297)|(625)|(109,922)|(200,172)|
|Other expenditure|||(689)||(689)|(655)|
|Total expenditure<br>Net (expenditure)/income|||(288,541)<br>~41,841|(625)<br> ~625|(289,166)<br>42,466|(429,171)<br>9,214|
|Net movement<br>in funds|||(41,841)|(625)|(42,466)|9,214|
|Reconciliation<br>of|funds||||||
|Total funds brought|forward||546,870|1,065|547,935|538,721|
|Total funds carried|forward|18|505,029|440|505,469|547,935|





## 

## 

||||2021|2020|
|---|---|---|---|---|
|||Note|||
|Fixed assets|||||
|Tangible assets||13|2,032|2,500|
|Current assets|||||
|Stocks|||12,011|11,588|
|Debtors||15|8,948|4,797|
|Cash at bank and in|hand||499,688|546,711|
||||520,647|563,096|
|Creditors: Amounts|falling due within one year|16|17,210)|(17,661|
|Net current assets|||503,437|545,435|
|Net assets|||505,469|547,935|
|Funds ofthe group:|||||
|Restricted<br>income funds|||||
|Restricted<br>funds|||440|1,065|
|Unrestricted<br>income funds|||||
|Unrestricted<br>funds|||505,029|546,870|
|Total funds||18|505,469|547,935|





## 

## 

|||||2021|2020|
|---|---|---|---|---|---|
||||Note|||
|Fixed assets||||||
|Investments||||100|100|
|Current assets||||||
|Debtors|||15|61,423|61,294|
|Cash at bank|and in hand|||448,972|489,427|
|||||510,395|550,721|
|Creditors: Amounts||falling due within one year|16|2,520|2,394|
|Net current assets||||507,875|548,327|
|Net assets||||507,975|548,42?|
|Funds ofthe|charity:|||||
|Restricted income funds||||||
|Restricted funds||||440|1,065|
|Unrestricted|income|funds||||
|Unrestricted<br>funds||||507,535|547,362|
|Total funds||||507,975|548,427|





## 

## 

|Consolidated<br>Statemen|t ofCash F|lows for t|he Year En|ded 30Septem|ber<br>2021|
|---|---|---|---|---|---|
|||||2021|2020|
||||Note|E||
|Cash flows from operating|activities|||||
|Net cash (expenditure)/income||||(42,466)|9,214|
|Adjustments<br>to cash flows|from non-cash|items||||
|Depreciation||||1,446|1,546|
|Investment<br>income||||224|1,253|
|||||(41,244)|9,507|
|Working capital adjustments||||||
|(Increase)/decrease<br>in stocks||||(423)|510|
|(increase)/decrease<br>in debtors|||15|(4,151)|12,420|
|Decrease<br>in creditors|||16|(451)|(7,373)|
|Net cash flows from operating|activities|||(46,269)|15,064|
|Cash flows from investing<br>activities||||||
|Interest receivable<br>and similar|income||4|224|1,253|
|Purchase<br>oftangible<br>fixed assets|||13|978||
|Net cash flows from investing|activities||||1,253|
|Net (decrease)/increase<br>in cash and cash equivalents||||(47,023)|16,317|
|Cash and cash equivalents<br>at|1 October|||546,711|530,394|
|Cash and cash equivalents<br>at|30 September|||499,688|546,711|





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

|2<br>Income from donations<br>and legacies||||
|---|---|---|---|
||Unrestricted|||
||funds|Total|Total|
||General|2021|2020|
|Donations<br>and legacies;||||
|Donations<br>and gifts|5,514|5,514|5,402|
|Legacies and funeral donations|2,980|2,980|142,369|
|Income tax and gift aid|1,132|1,132|980|
||9,626|9,626|148,751|





## 

## 

## 

|3<br>Inco|me fro|m othe|r trading<br>activities||||
|---|---|---|---|---|---|---|
|||||Unrestricted|||
|||||funds|Total|Total|
|||||General<br>f|2021|2020|
|Trading|income;||||||
|Commercial||trading|operations|202,156|202,156|282,578|
|Events|income;||||||
|Other|events|income||||1,715|
|||||202,161|202,161|284,293|



## 

||||Unrestricted||||
|---|---|---|---|---|---|---|
||||funds|Total||Total|
||||General|2021||2020|
|||||E|||
|Other|investment|income|224||224|1,253|



## 

|5<br>Other|incom|e||||
|---|---|---|---|---|---|
||||Unrestricted|||
||||funds|Total|Total|
||||General<br>K|2021f|2020|
|Other operating||income|1,082|1,082||
|CJRS income|||3,931|3,931|4,088|
|Insurance|payout||29,676|29,676||
||||34,689|34,689|4,088|





## 

## 

## 

## 

|a) Costs of|gene|rating<br>donations<br>and legacies||||
|---|---|---|---|---|---|
||||Total|Total||
||||2021|2020||
||||F|F||
|Fund-raising|and|publicity|||532|



## 

|b) Cos|ts oftradin|g<br>activities|||||
|---|---|---|---|---|---|---|
|||||Unrestricted|||
|||||funds|Total|Total|
|||||General|2021|2020|
||||Note||||
|Trading|subsidiary|costs|11|178,555|178,555|227,812|
|||||178,555|178,555|227,812|



## 

|7<br>Expen|ditu|re<br>on c|haritable<br>a|ctivities|||||
|---|---|---|---|---|---|---|---|---|
|||||Unrestricted|||||
|||||funds|Restricted|Total|Total||
|||||General|funds|2021|2020||
||||Note||F|f,|F||
|Allocated|support||||||||
|costs||||689||689||655|
|Governance||costs||2,520||2,520|2,394||
|Donations|to|YDH|||||||
|NHS Foundation|||||||||
|Trust||||106,777|625|107,402|191,478||
|Donations|to|Yeovil|||||||
|Freewheelers|||||||6,300||
|||||109,986|625|110,611|200,827||





## 

## 

## 

## 


## 

|||||||Unrestricted|||
|---|---|---|---|---|---|---|---|---|
|||||||funds|Total|Total|
|||||||General|2021|2020|
|||||||||E|
|Independent||examiner|fees||||||
||Examination|ofthe financial|||statements|1,380|1,380|1,254|
||Other fees|paid to examiners||||1,140|1,140|1,140|
|||||||2,520|2,520|2,394|
|9|Net incoming/outgoing|||resources|||||
|Net (outgoing)/incoming|||resources for the year include:||||||
||||||||2021f|2020f|
|Independent||examiner's|fees||||2,520|2,394|
|Depreciation||offixed assets|||||1,446|1,546|



## 

## 



## 

## 

## 

## 

|Subsidary<br>Profit and Loss|Subsidary<br>Profit and Loss|Subsidary<br>Profit and Loss||2021|2020|
|---|---|---|---|---|---|
|||||f||
|Turnover||||202,156|282,578|
|Cost ofsales||||(125,753)|(172,000)|
|Gross profit||||76,403|110,578|
|Other operating||income||35,952|5,193|
|Administrative|expenses|||(52,802)|(55,812)|
|Net Profit||||59,553|59,959|
|Reserves<br>brought<br>forward||||59,467|71,405|
|Distribution<br>to|The League of Friends ofYeovil||Hospitals|(61,505)|(71,897)|
|Retained<br>in Subsidiary||||57,515|59,467|
|The assets and||liabilities ofthe subsidiary|were|2021|2020|
|Fixed assets||||2,032|2,500|
|Current assets||||70,273|72,334|
|Current<br>liabilities||||(14,690)|(15,267)|
|Total net assets||||57,615|59,567|
|Share capital||||100|100|
|Reserves||||57,515|59,467|
|Total equity||||57,615|59,567|





## 

## 

## 

|||||||2021f|2020|
|---|---|---|---|---|---|---|---|
|Staff costs during||the|year were:|||||
|Wages and salaries||||||43,079|47,375|
|Staff pensions|(defined||contribution)|||1,360|1,577|
|||||||44,439|48,952|
|The average|number|of|persons|employed|during the year was as follows:|||
|||||||2021|2020|



## 

## 

|Group||||
|---|---|---|---|
||Fixtures and|Office||
||fittings|equipment|Total|
|||E|F|
|Cost||||
|At 1 October 2020|18,469||18,469|
|Additions<br>Disposals|4,554)|978|978<br>~4,554|
|At 30September 2021|13,915|978|14,893|
|Depreciation||||
|At 1 October 2020|15,969||15,969|
|Charge for the year<br>Eliminated<br>on disposals|1,250<br>4,554|196|1,446<br>~4,554|
|At 30September 2021|12,665|196|12,861|
|Net book value||||
|At 30September 2021|1,250|782|2,032|
|At 30September 2020|2,500||2,500|





## 

## 

## 

## 

## 

|Shares in group undertakings<br>and participatin|g<br>interests||
|---|---|---|
||Subsidiary||
||undertakings|Total|
|||F|
|Cost|||
|At 1 October 2020|100|100|
|At 30September 2021|100|100|
|Net book value|||
|At 30September 2021|100|100|
|At 30September 2020|100|100|



## 

|15Debtors|||||
|---|---|---|---|---|
||Group||Charity||
||2021|2020|2021f|2020<br>E|
|Accrued income|||60,021|59,959|
|Other debtors|8,948|4,797|1,402|1,335|
||8,948|4,797|61,423|61,294|



## 

## 

|16Creditors:|amounts<br>falling|due within one year||||
|---|---|---|---|---|---|
|||Group||Charity||
|||2021|2020|2021|2020|
|||E||||
|Trade creditors||8,545|9,088|||
|Other taxation|and social|||||
|security||668|802|||
|VAT grant repayable||2,188|2,190|||
|Other creditors||1,310|1,238|||
|Accruals||4,499|4,343|2,520|2,394|
|||17,210|17,661|2,520|2,394|





## 

## 

## 

## 

## 

## 

|Group||||||||
|---|---|---|---|---|---|---|---|
||||||||Balance at 30|
|||||Balance at 1|Incoming|Resources|September|
|||||October 2020|resources|expended|2021|
|||||||F|E|
|Unrestricted<br>funds||||||||
|General||||||||
|Unrestricted<br>general|||funds|163,246|246,700|(240,175)|169,771|
|Designated||||||||
|Children's|outpatients|||300,000|||300,000|
|Other designated||funds||83,624||48,366|35,258|
|||||383,624||(48,366)|335,258|
|Total unrestricted||funds||546,870|246,700|288,541|505,029|
|Restricted|funds|||||||
|Chemotherapy<br>unit||||66|||66|
|Macmillan|unit Barrie||Ackland|85|||85|
|Ward 8B|Daphne|I Tulk||175|||175|
|Mrs H M Ward patients||||||||
|vouchers|for shop|||625||(625)||
|Macmillan|unit John Hicks|||114|||114|
|Total restricted funds||||1,065||625|440|
|Total funds||||547,935|246,700|289,166|505,469|





## 

## 

|||||||Balance at 30|
|---|---|---|---|---|---|---|
||||Balance at 1|Incoming|Resources|September|
||||October 2019|resources|expended|2020|
|Unrestricted<br>funds|||||||
|General|||||||
|Unrestricted<br>general funds|||127,338|137,596|(101,688)|163,246|
|Designated|||||||
|Children's|outpatients||300,000|||300,000|
|Other designated||funds|111,057||(27,433)|83,624|
||||411,057||(27,433|383,624|
|Total unrestricted||funds|538,395|137,596|129,121)|546,870|
|Restricted|funds||||||
|Chemotherapy<br>unit|||66|||66|
|Macmillan|unit Barrie Ackland||85|||85|
|Ward 8B|Daphne|I Tulk|175|||175|
|Mrs H M Ward patients|||||||
|vouchers|for shop|||625||625|
|Donation|towards|Hearts||50|(50)||
|Macmillan|unit John Hicks|||114||114|
|Total restricted<br>funds|||326|789|50|1,065|
|Total funds|||538,721|138,385|129,171|547,935|





## 

## 

## 

|Group|||||
|---|---|---|---|---|
|||||Total funds|
|||Unrestricted||at 30|
|||funds|Restricted|September|
|||General<br>f|funds|2021|
|Tangible|fixed assets|2,032||2,032|
|Current|assets|520,207|440|520,647|
|Current|liabilities|17,210)||17,210|
|Total net assets||505,029|440|505,469|
|||||Total funds|
|||Unrestricted||at 30|
|||funds|Restricted|September|
|||General|funds|2020|
|Tangible|fixed assets|2,500||2,500|
|Current|assets|562,031|1,065|563,096|
|Current|liabilities|(17,661||(17,661|
|Total net assets||546,870|1,065|547,935|



## 

## 

## 

